Cremer, J., Brohée, L., Colige, A., & Deroanne, C. (11 October 2022). Acidosis-induced regulation of adipocyte G0S2 promotes the crosstalk between adipocytes and cancer cells as well as tumor progression [Poster presentation]. Cancer Metabolism, Bilbao, Spain. |
Cremer, J., Brohée, L., Colige, A., & Deroanne, C. (29 June 2022). The role of adipocyte G0/G1 switch gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes [Poster presentation]. Turin Metabolism, Turin, Italy. |
![]() ![]() | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Herfs, M., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (01 July 2018). Myoferlin controls mitochondrial structure and metabolism in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. EACR 25 50 Years, Amsterdam, Netherlands. |
![]() ![]() | Brohée, L., Peulen, O., Nusgens, B., Castronovo, V., Thiry, M., Colige, A., & Deroanne, C. (04 May 2018). Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Scientific Reports, 8 (1), 7050. doi:10.1038/s41598-018-25340-9 ![]() |
![]() ![]() | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège. |
![]() ![]() | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress. |
![]() ![]() | Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium. |
Brohée, L. (2017). Lipin-1 regulates cancer cell phenotype and is a potential target to amplify the effect of metabolic inhibitors [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/214145 |
![]() ![]() | Hendricks, C., Dubail, J., Brohée, L., Delforge, Y., Colige, A.* , & Deroanne, C.*. (2016). A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo. PLoS ONE. doi:10.1371/journal.pone.0165153 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Brohée, L., Demine, S., Willems, J., Arnould Thierry, Colige, A., & Deroanne, C. (10 May 2015). Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment. Oncotarget, 6 (13), 11264-11280. doi:10.18632/oncotarget.3595 ![]() |
![]() ![]() | Brohée, L., Bastin, R., Wingert, S., Netter, P., Waltz, C., Delvenne, P., & Jacobs, N. (2013). Expansion of CD16+ CD56+ NK cells in vericyte® NK cell growth medium [Poster presentation]. 14th Meeting of the Society for Natural Immunity, Heidelberg, Germany. |